Verinomics

Verinomics

Private
Branford, ConnecticutFrontier & Industrial Techhttps://verinomics.com

Last Round

Series A

May 1, 2025

Total Funding Raised

$14M

Momentum Score

25 /100

Company Overview

Verinomics is an AgTech and biotechnology company that develops enhanced varieties of fruits, vegetables and tree nuts through a platform combining advanced genomics, computational biology, and precision transgene-free gene editing.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

gene editingtransgene-free gene editingagtechaccelerated breedingprecision breedingcrop developmentgenomicstrait discoverycomputational biologyagricultural biotechnologyag-biotechAI genomicsspecialty cropsdisease resistanceco-development model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Verinomics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Verinomics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMay 1, 2025
GrantSep 19, 2024
GrantFeb 12, 2024
SeedJan 3, 2019

Key People

Founding team and executive leadership

Gio Scalzo

Chief Operating Officer

Executive Team

Verinomics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 537% MoM, from 231 to 1.5K.

  • Mar 24, 2025

    Added Innovativegenomics, a biotechnology/genomics startup.

Verinomics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Verinomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Verinomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBranford, Connecticut
Employee Range17
Year Founded2022
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.